Latest News
Emeramide, a safe metals chelator and antioxidant
Emeramide is an exceptionally safe and effective lipophilic, blood-brain-barrier passing metal chelator and antioxidant being developed by EmeraMed Limited. It is currently going through the European Medical Agency (EMA) and the United States Food and Drug Administration (FDA) drug approval process.
Warning: Counterfeit Emeramide sold illegally in EU & USA
Counterfeit Emeramide is being sold under our various trade names (OSR#1®, NBMI) and tests have shown that it is not Emeramide. Emeramide may be available in your country in compliance with various regulations through our Early Access Programme.
In The Press
Research
The most current, up-to-date information on our research.
Clinical Trials
The most current, up-to-date information on our clinical trials.
Study results from mercury poisoned gold miners
Mercury chelator Emeramide produced outstanding results in safety and efficacy despite the fact that gold miners were overwhelmed with continuous mercury exposure.
Newsletters
Stay up-to-date on EmeraMed with our company newsletters.
EmeraMed Newsletter: June, 2020
EmeraMed Newsletter June, 2020 We hope this finds each of you and your families safe and healthy. We are pleased to update you on the status of our projects [...]
EmeraMed Newsletter: February, 2019
February 2019 Newsletter for EmeraMed Ltd, a biotechnology firm developing the lipophilic, blood-brain-barrier passing metal chelator & antioxidant Emeramide®
Discover The Future of Health
We are committed to improving health by way of our unique metal chelator and antioxidant, Emeramide